4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-018384
CEO & Chief Scientific Officer acquired 139,716 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Scientific Officer | 2018-03-15 | Grant or award | +98,029 | 2,111,194 | D | ||
| Zhang Jack Y. CEO & Chief Scientific Officer | 2018-03-15 | Grant or award | +41,687 | 1,372,333 | I | ||
| Derivatives | |||||||
| Zhang Jack Y. CEO & Chief Scientific Officer | 2018-03-15 | Grant or award · Employee Stock Option (right to buy) | +273,692 | 273,692 | D | ||
| Zhang Jack Y. CEO & Chief Scientific Officer | 2018-03-15 | Grant or award · Employee Stock Option (right to buy) | +116,392 | 116,392 | I | ||
Loading xslF345X03/a4.xml…